Marshall Wace LLP trimmed its position in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 98.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,164 shares of the company's stock after selling 765,555 shares during the period. Marshall Wace LLP's holdings in Keurig Dr Pepper were worth $455,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of KDP. New Age Alpha Advisors LLC raised its holdings in shares of Keurig Dr Pepper by 82.8% during the 4th quarter. New Age Alpha Advisors LLC now owns 859 shares of the company's stock worth $28,000 after acquiring an additional 389 shares in the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Keurig Dr Pepper during the 4th quarter valued at $37,000. Edmond DE Rothschild Holding S.A. acquired a new stake in Keurig Dr Pepper in the 4th quarter worth approximately $42,000. Brooklyn Investment Group boosted its holdings in shares of Keurig Dr Pepper by 34.0% in the 4th quarter. Brooklyn Investment Group now owns 2,184 shares of the company's stock valued at $70,000 after acquiring an additional 554 shares during the last quarter. Finally, R Squared Ltd acquired a new position in shares of Keurig Dr Pepper in the 4th quarter valued at $70,000. 93.99% of the stock is owned by hedge funds and other institutional investors.
Keurig Dr Pepper Trading Down 0.7 %
KDP traded down $0.23 during midday trading on Friday, hitting $33.91. The company's stock had a trading volume of 3,199,699 shares, compared to its average volume of 10,425,890. The firm has a market cap of $46.06 billion, a P/E ratio of 20.55, a PEG ratio of 2.42 and a beta of 0.52. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $34.21 and a two-hundred day moving average price of $33.08. Keurig Dr Pepper Inc. has a 52-week low of $30.12 and a 52-week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. The business had revenue of $3.64 billion during the quarter, compared to the consensus estimate of $3.57 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The business's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.38 earnings per share. On average, research analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.23 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.71%. Keurig Dr Pepper's dividend payout ratio (DPR) is presently 83.64%.
Insiders Place Their Bets
In related news, Chairman Robert James Gamgort sold 416,000 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $34.29, for a total transaction of $14,264,640.00. Following the transaction, the chairman now directly owns 3,237,066 shares of the company's stock, valued at $110,998,993.14. The trade was a 11.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $34.05, for a total transaction of $408,600.00. Following the completion of the transaction, the insider now directly owns 187,537 shares in the company, valued at $6,385,634.85. This represents a 6.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 84,863,850 shares of company stock valued at $2,772,203,450 in the last ninety days. Corporate insiders own 1.00% of the company's stock.
Wall Street Analysts Forecast Growth
KDP has been the subject of a number of analyst reports. Piper Sandler upgraded Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and upped their price target for the company from $35.00 to $40.00 in a research report on Wednesday, April 9th. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research note on Friday, April 25th. Barclays boosted their target price on Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. HSBC upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their price target for the stock from $36.00 to $42.00 in a research note on Friday, April 25th. Finally, UBS Group raised their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Four analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $39.33.
Read Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.